The lawsuit itself is not new. The Republican attorneys general of Texas and Florida filed it on Dec. 9, 2025, asking the court to strip mifepristone of the FDA approval it has carried since the year 2000. Their complaint argues the agency never properly evaluated the drug's safety and effectiveness, and it leans in part on the Comstock Act, an 1873 statute restricting the mailing of abortion-related materials that has sat largely dormant for generations.
In the same order, Judge O'Connor turned down a motion from the drug's manufacturer, GenBioPro, to dismiss the case outright, leaving the lawsuit alive but frozen in place. GenBioPro's chief executive, Evan Masingill, said the company expects the FDA's coming review "to not contradict" the agency's 2023 finding that reaffirmed mifepristone as safe and effective.
The numbers behind the fight are large. More than 7.5 million people in the United States took mifepristone between its 2000 approval and the end of 2024, with 36 deaths associated with its use reported to the FDA over that span. By 2023, medication abortion accounted for 63 percent of all abortions performed in the country, a share that keeps climbing as surgical procedures become rarer.
A Court Can Set a Date. It Cannot Set the Facts.
December will come, and the FDA will hand down its findings, and lawyers on both sides will argue about what those findings mean. But whatever a review board decides about labeling and dosage and reported harm, none of it touches the one fact this whole fight is really about: what is present in a womb from the very first moment, and to whom that small life belongs.
That question was answered a long time before Roe v. Wade, and it will still be answered the same way after this case is finally heard, whenever that day comes.
"Before I formed thee in the belly I knew thee; and before thou camest forth out of the womb I sanctified thee, and I ordained thee a prophet unto the nations." (Jeremiah 1:5)
Notice what the Lord did not say. He did not say He would know that child once it could survive outside the womb, or once a heartbeat could be measured, or once a court decided it qualified for protection. He said He knew Jeremiah before He formed him — while he was still nothing the world could see, weigh, or vote on. The same God who spoke those words over a prophet in Judah speaks them still over every child conceived in Texas, in Florida, in every state whose legislature argues the matter this year.
My friend, a pending FDA review is a fine thing for regulators to sort through. Safety data matters, and a nation ought to know what it is putting into the bodies of its citizens. But do not mistake a paused lawsuit for a paused conscience. Somewhere tonight, a woman is holding a pill in her hand and does not know that the God of Jeremiah already knows the child inside her by name. She needs more than a delayed court date. She needs to hear that there is a Savior who forgives, who heals, who does not turn away the frightened or the desperate, and who died so that guilt over what has already been done need never be the final word.
The gospel does not wait on the FDA's calendar either. Christ went to the cross for the abortionist and the woman in the clinic waiting room just as surely as He went for the judge on the bench and the senator writing the law. There is no sin His blood cannot cover, and no life — born or unborn, healed or grieving — outside the reach of His mercy.
Whatever December brings, hold to this: the child in the womb was known before the world had judges to argue about it, and the sinner reaching for grace is known just as surely now.